The Koch's Bacillus is a bacterium, the primary causative agent of tuberculosis. It was first identified by the German microbiologist Robert Koch in 1882, hence its name. Tuberculosis is transmitted from person to person through the air when an infected individual coughs, sneezes, or speaks. Common symptoms of TB include chronic cough with sputum production, often with blood, weight loss, night sweats, fever, fatigue, and weakness. The treatment of tuberculosis is typically lengthy and involves taking several antibiotics for at least 6 months. Early diagnosis and consistent treatment are key to preventing the spread of the disease and the development of drug resistance. #: Local Health System Sustainability Project (LHSS) USAID This project was made possible by the support of the American people, provided through the United States Agency for International Development (USAID) under the Sustainable Health Systems Development Project grant. The content of this publication is the responsibility of LLC "NK Group Consulting" and does not necessarily reflect the views of USAID or the United States Government. 📌 Our app ⤵️📱 https://bit.ly/m/docdoc Facebook - https://lnkd.in/dqxbzyfm LinkedIn - https://lnkd.in/d7-QQtkx
Doc Doc - non profit telehealth platform’s Post
More Relevant Posts
-
Watch U.S. Department of Health and Human Services (HHS) Secretary Becerra announce our TARGET project, which will use AI to speed the discovery and development of new classes of antibiotics, at #UNGA. https://lnkd.in/e8Ri3Rns “Antibiotic resistance is a real and urgent threat affecting millions of people. We need to prevent infections and conserve the antibiotics we have. We also urgently need new drugs to treat these increasingly resistant infections. This project will use AI to speed this needed innovation and help ensure we have the medicines we need to keep people alive.”
To view or add a comment, sign in
-
Consultant in Infectious Diseases and Acute Medicine/ Honorary Senior Clinical Lecturer at Imperial College, London/ Infectious Diseases Advisor to MSF OCA
Thanks for sharing - beyond low resource settings - countries affected by protracted #conflict like #Syria face many challenges in defining and addressing #AMR Across #Syria - chronic under investment, ongoing violence, restricted access to equipment and supplies, limited #education & #training and a lack of priotisation (given multiple other life saving priorities in an underfunded humanitarian response) - pose challenges particularly in areas outside of government control (north west and north east Syria) For Syria and other countries affected by conflict including #Gaza, #Yemen, #Sudan, #Ukraine - AMR will remain endemic unless there is a cessation of hostilities and the required investment in programs which address and response to AMR contextually Our full article is here: https://lnkd.in/gpvX5w2g
🌟LIVE | ISAC / ESCMID webinar🌟 AMR in low resource settings and / or displaced populations Dr Rana Hajjeh (Ex WHO EMRO Director of Programme Management & Communicable Diseases, USA) is our second expert speaker who is presenting on "AMR in low resource settings in the MENA region" Join the session ⬇ https://lnkd.in/eryeGib4 #superbugs #infectiousdisease #clinicalmicro #healthcare #antibioticresistance #antibiotics #antimicrobialstewardship #antimicrobialresistance #antimicrobials #clinicalmicrobiology #globalhealth #publichealth #healthcare #escmid
To view or add a comment, sign in
-
It's worth acknowledging the fact that no woman is immune from breast diseases. Examination by a mammologist should become a regular procedure, even if there are no complaints. As soon as breast growth and development begin, constant monitoring by a mammologist is necessary. 👩🏻⚕️ Preventive visits to the mammologist: 🔸 Up to the age of 30 - once a year; 🔸 From 30 to 50 years old - twice a year and mammography once every 1-2 years; 🔸 After 50 - once a year and annual mammography. 🍒 Additionally, we recommend performing self-examination of the breasts monthly, on days 6-12 of the menstrual cycle #: Local Health System Sustainability Project (LHSS) USAID This project was made possible by the support of the American people, provided through the United States Agency for International Development (USAID) under the Sustainable Health Systems Development Project grant. The content of this publication is the responsibility of LLC "NK Group Consulting" and does not necessarily reflect the views of USAID or the United States Government. 📌 Our app ⤵️📱https://bit.ly/m/docdoc Facebook - https://lnkd.in/dqxbzyfm LinkedIn - https://lnkd.in/d7-QQtkx
Doc Doc
facebook.com
To view or add a comment, sign in
-
Strategic investments in bolstering #connectivity infrastructure can facilitate more timely diagnosis, management, and treatment of TB. Digital adherence technologies like SMS reminders offer #healthcare providers an efficient means of notifying patients of test results and tracking and managing treatment and care regimens. Learn more about how connectivity solutions are revolutionizing TB patient care: https://lnkd.in/exYu8Zyx #digitaladherence #healthsystem #healthtech
Improving Connectivity to Enhance the FIght Against TB — PSC
pscstoptb.org
To view or add a comment, sign in
-
Interesting course to gain insight into the global response to the COVID-19 pandemic, and how innovations can be used to leverage AMR diagnostics. #LondonSchoolHygieneTropicalMedicine #LSHTM
Diagnostics for AMR: Building Back Better from the COVID-19 Pandemic | LSHTM
lshtm.ac.uk
To view or add a comment, sign in
-
🦠 𝐔.𝐒 𝐆𝐚𝐦𝐞 𝐂𝐡𝐚𝐧𝐠𝐞𝐫: 𝐒𝐚𝐦𝐩𝐥𝐞-𝐏𝐫𝐞𝐩-𝐅𝐫𝐞𝐞 𝐌𝐨𝐥𝐞𝐜𝐮𝐥𝐚𝐫 𝐓𝐞𝐬𝐭𝐢𝐧𝐠 🦠 3EO Health just launched the first "High Efficiency" Molecular Platform, making accurate, easy-to-use testing a reality for everyone. 𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐭𝐡𝐞 𝐛𝐞𝐧𝐞𝐟𝐢𝐭𝐬? 𝑼𝒍𝒕𝒓𝒂-𝒂𝒇𝒇𝒐𝒓𝒅𝒂𝒃𝒍𝒆: Tests cost under $20, a fraction of traditional molecular options. 𝑵𝒐 𝒔𝒂𝒎𝒑𝒍𝒆 𝒑𝒓𝒆𝒑 𝒉𝒆𝒂𝒅𝒂𝒄𝒉𝒆𝒔: Skip the messy mixing and pipetting - just swab and go! 𝑺𝒖𝒑𝒆𝒓 𝒔𝒑𝒆𝒆𝒅𝒚: Get results in minutes, right at the doctor's office or even at home. 𝑪𝒍𝒊𝒏𝒊𝒄𝒂𝒍𝒍𝒚 𝒑𝒓𝒐𝒗𝒆𝒏: This FDA-authorized test is 1000x more sensitive than antigen tests, catching even tricky variants. 3EO Health are reportedly giving away their testing analyzers for free to US physician offices. This isn't just about COVID-19. 3EO Health's platform paves the way for affordable, accessible molecular testing for a wide range of diseases. Imagine a world where everyone can take control of their health with instant, reliable results. #MolecularDiagnostics #3EOHealth #Testing #AffordableHealthcare
3EO Health
3eohealth.com
To view or add a comment, sign in
-
This World Thalassemia Day, the Aleem Dar Foundation is registering thalassemia patients for free at the Aleem Dar Thalassemia Center. Please spread the word so that we can help as many patients as we can. Timings will be 10 am to 3 pm #AleemDar #aleemdarfoundation #umpirescallforhumanity #thalassemiafreepakistan #thalassemiaawareness
To view or add a comment, sign in
-
🏥 In Europe, financially constrained healthcare systems need to cope with an ageing population, rising chronic diseases, epidemics such as Covid-19, increasing costs, new technologies, exploding data and a lack of healthcare workers. 💡 How can In Vitro Diagnostics (IVD) help in such a context? Find out more in this new bioMérieux's blog article. 👇
Adding value to patient care and outcomes in hospitals | bioMérieux's Blog 📝
share.biomerieux.com
To view or add a comment, sign in
-
Chargée de communication et d'organisation d'évènements Département "R&D - Open Innovation and Partnerships"
🏥 In Europe, financially constrained healthcare systems need to cope with an ageing population, rising chronic diseases, epidemics such as Covid-19, increasing costs, new technologies, exploding data and a lack of healthcare workers. 💡 How can In Vitro Diagnostics (IVD) help in such a context? Find out more in this new bioMérieux's blog article. 👇
Adding value to patient care and outcomes in hospitals | bioMérieux's Blog 📝
share.biomerieux.com
To view or add a comment, sign in
-
There's a lack of understanding about rare diseases among the public, some medical professionals, and even policymakers. The conference aims to raise awareness by sharing patient stories, disseminating educational resources, and promoting community engagement. Increased awareness leads to earlier recognition of symptoms, improved support systems, and reduced stigma. Join us on May 25th, 2024, at the "Rare Visions Shared Future: Uniting for Progress" We'd like to invite you to visit the website at https://lnkd.in/dFwvrEGG to explore the exciting program. For registration: https://lnkd.in/duC2VZVR #RareVisions2024 #UnitingForProgress #RareDiseasesConference #RareDiseaseAwareness #ShineALight #RareDiseaseCommunity #Ministry_of_Health_Saudi_Arabia #Saudi_Society_of_Clinical_Pharmacy #Riyadhome #SaudiHealthcare #HealthcareRevolution #HealthcareInfrastructure #EventManagement ##ScientificEvents #MedicalConferences #eventsuccess #Saudi_Events #Gulf_Events #HealthcareInnovation #Aztrazeneca #Roche #Sanofi #Novartis #Biogen #GenPharm #Boehringer_ingelheim #Takeda #Moderna #Biomarin #sobi
To view or add a comment, sign in
14 followers